Profile of Tuberculosis in AL-Diwanyah Governorate, Iraq

Akram H. Kareem; Dheyaa J. Kadhim

Profile of Tuberculosis in AL-Diwanyah Governorate, Iraq

Akram H. Kareem, Dheyaa J. Kadhim

Abstract

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. It is considered one of the most important infectious diseases in the world and its incidence is on the rise. This retrospective study aimed to provide detailed information of the tuberculosis patients in AL-Diwanyah Governorate/Iraq. A total of 488 TB patients were involved in this study. The data related to current study were collected from the Advisory clinics for Chest Diseases located in six health sectors covering the geographical distribution of the AL-Diwaniya governorate. The number of female tuberculosis patients was 263 (53.89%) which was significantly higher than the number of male tuberculosis patients which was 225 (46.11%). In addition, 374 (76.64%) patients had pulmonary tuberculosis and 114 (23.36%) patients had extra-pulmonary tuberculosis. The percentage of pulmonary tuberculosis was significantly higher in patients older than 40 years and the percentage of extra-pulmonary TB was significantly higher in patients younger than 40 years (P < 0.05). The cure rate was significantly higher in patients with pulmonary TB than in extra-pulmonary TB patients. Treatment success was reported in 466 (95.49%) patients, death in 10 (2.05%), treatment failure in 7 (1.43%) and discontinuation of treatment in 5 (1.02%) patients. Their rate of pulmonary tuberculosis was significantly higher in diabetic than non-diabetic patients while the rate of cure was significantly higher in non-diabetic patients than in diabetic patients. Pulmonary tuberculosis was significantly higher in smokers than in non-smokers. In conclusion, the rate of successful treatment is high and the rate of relapsed tuberculosis cases is lower among tuberculosis patients in AL-Diwaniya governorate. Socieodemographic factors significantly influence the profile of TB in AL-Diwaniya governorate.

Keywords

tuberculosis, AL-Diwaniya, Iraq

Full Text:

References

De Backer AI, Mortelé KJ, De Keulenaer BL, Parizel PM. Tuberculosis: epidemiology, manifestations, and the value of medical imaging in diagnosis. JBR–BTR. 2006;89:243–250.

Alistair S. Tuberculosis a general introduction. Pharmaceutical J. 2004;273:289–291.

Longmore M, Wilkinson IB, Turmezei TC, et al. Oxford Handbook of Clinical Medicine, 7th Edition. Copyright. ©Oxford University Press 2007.

The National Tuberculosis Control Program (NTP)-Iraq. Available at: (http://www.ntpiraq.zaghost.com/index.htm) (accessed at 1/10/2015).

Alfaresi MS, Hag-Ali M. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in United Emirati Hospital. Open Microbiol J. 2010;4:1–4.

World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision. Available at (www.who.net) (accessed at 1/9/2015).

CDC. The Difference between latent TB infection and Active TB disease. Website-www.cdc.gov/tb.:1-2. (Accessed at 15/9/2015).

WHO Report 2006: Global tuberculosis control surveillance, planning, financing. Geneva, World Health Organization, 2006.

Butcher SK, Chahal H, Nayak L, Sinclair A, Henriquez NV, Sapey E, et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukocyte Biol. 2001;70:881–886.

World Health Organization. Global Tuberculosis Control:Surveillance, Planning Financing. Geneva, World Health Organization, 2008.

World Health Organization. Diagnostic and treatment delay in tuberculosis. An in-depth analysis of the health-seeking behavior of patients and health system response in seven countries of the Eastern Mediterranean Region. Geneva, World Health Organization, 2006.

Mazza-Stalder J, Nicod L, Janssens JP. Extrapulmonary tuberculosis. Rev Mal Respir. 2012;29:566–578.

Angela RT, Emily IW. Tuberculosis: A Clinical Review. US Pharm. 2005;7:HS-14–HS-22.

Cailhol J, Decludt B, Che D. Sociodemographic factors that contribute to the development of extrapulmonary tuberculosis were identified. J Clin Epidemiol. 2005;58:1066–1071.

Gonzalez OY, Adams G, Teeter LD, et al. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178–1185.

Mackay AD, Cole RB. The problems of tuberculosis in the elderly. Q J Med. 1984;53:497–510.

Haytham M, Jafar A, Abdelmonem M, et al. The pattern of active pulmonary tuberculosis in adults at King Hussein Medical Center, Jordan. Saudi Med. J. 2006;27:633–636.

World Health Organization. Global tuberculosis report 2014. Available at (www.who.int). (Accessed at 1/8/2015).

Rayfield EJ, Ault MJ, Keusch GT, et al. Infection and diabetes: the case for glucose control. Am J Med. 1982;72:439–450.

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5:e152.

Phillips DE, Hill L, Weller P, et al. Tobacco smoke and the upper airway. Clin Otolaryngol. 2003;28:492–496.

Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:372–377.

Refbacks

There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Journal of Pharmaceutical and Biomedical Sciences